Subclinical Hypothyroidism and Lipid Metabolism: To Treat or Not to Treat?

1. Casu G, Gulizia MM, Molon G, Mazzone P, Audo A, Casolo G, Di Lorenzo E, Portoghese M, Pristipino C, Ricci RP, Themistoclakis S, Padeletti L, Tondo C, Berti S, Oreglia JA, Gerosa G, Zanobini M, Ussia GP, Musumeci G, Romeo F& Di Bartolomeo R. [ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus document: percutaneous left atrial appendage occlusion in patients with nonvalvular atrial fibrillation: indications, patient selection, competences, organization, and operator training]. Giornale italiano di cardiologia. 2016; 17: 594-613.Search in Google Scholar

2. Casu G, Gulizia MM, Molon G, Mazzone P, Audo A, Casolo G, Di Lorenzo E, Portoghese M, Pristipino C, Ricci RP, Themistoclakis S, Padeletti L, Tondo C, Berti S, Oreglia JA, Gerosa G, Zanobini M, Ussia GP, Musumeci G, Romeo F& Di Bartolomeo R. ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus Document: percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation patients: indications, patient selection, staff skills, organisation, and training. European heart journal supplements: journal of the European Society of Cardiology. 2017; 19: D333-D353.10.1093/eurheartj/sux008552075928751849Search in Google Scholar

3. Casu G& Merella P. Diuretic Therapy in Heart Failure - Current Approaches. European Cardiology. 2015; 10: 42-47.10.15420/ecr.2015.10.01.42615946530310422Search in Google Scholar

4. De Ferrari GM, Perna GP, Nicosia A, Guasti L, Casu G, Cuccia C, Picco F, Strazzella C, Totaro R, Cercone S, Canullo L, Horack M, Lautsch D, Gitt AK& Di Biase M. Available oral lipid-lowering agents could bring most high-risk patients to target: an estimate based on the Dyslipidemia International Study II-Italy. Journal of cardiovascular medicine. 2018; 19: 485-490.10.2459/JCM.000000000000068029917002Search in Google Scholar

5. Scuteri A, Morrell CH, Orru M, Strait JB, Tarasov KV, Ferreli LA, Loi F, Pilia MG, Delitala A, Spurgeon H, Najjar SS, AlGhatrif M& Lakatta EG. Longitudinal perspective on the conundrum of central arterial stiffness, blood pressure, and aging. Hypertension. 2014; 64: 1219-1227.10.1161/HYPERTENSIONAHA.114.04127423101225225210Search in Google Scholar

6. Veronese N, Cereda E, Stubbs B, Solmi M, Luchini C, Manzato E, Sergi G, Manu P, Harris T, Fontana L, Strandberg T, Amieva H, Dumurgier J, Elbaz A, Tzourio C, Eicholzer M, Rohrmann S, Moretti C, D'Ascenzo F, Quadri G, Polidoro A, Lourenco RA, Moreira VG, Sanchis J, Scotti V, Maggi S& Correll CU. Risk of cardiovascular disease morbidity and mortality in frail and pre-frail older adults: results from a meta-analysis and exploratory meta-regression analysis. Ageing research reviews. 2017; 35: 63-73.10.1016/j.arr.2017.01.003604774728143778Search in Google Scholar

7. Costantino S, Paneni F& Cosentino F. Ageing, metabolism and cardiovascular disease. The Journal of Physiology. 2016; 594: 2061-2073.10.1113/JP270538493311426391109Search in Google Scholar

8. Scuteri A, Morrell CH, Orru M, AlGhatrif M, Saba PS, Terracciano A, Ferreli LA, Loi F, Marongiu M, Pilia MG, Delitala A, Tarasov KV, Schlessinger D, Ganau A, Cucca F& Lakatta EG. Gender specific profiles of white coat and masked hypertension impacts on arterial structure and function in the SardiNIA study. International journal of cardiology. 2016; 217: 92-98.10.1016/j.ijcard.2016.04.172520690127179214Search in Google Scholar

9. Jarvik GP, Austin MA, Fabsitz RR, Auwerx J, Reed T, Christian JC& Deeb S. Genetic influences on age-related change in total cholesterol, low density lipoproteincholesterol, and triglyceride levels: longitudinal apolipoprotein E genotype effects. Genetic epidemiology. 1994; 11: 375-384.10.1002/gepi.13701104077813899Search in Google Scholar

10. Delitala AP, Capobianco G, Delitala G, Cherchi PL& Dessole S. Polycystic ovary syndrome, adipose tissue and metabolic syndrome. Archives of gynecology and obstetrics. 2017; 296: 405-419.10.1007/s00404-017-4429-228643028Search in Google Scholar

11. Cappola AR& Ladenson PW. Hypothyroidism and atherosclerosis. The Journal of clinical endocrinology and metabolism. 2003; 88: 2438-2444.10.1210/jc.2003-03039812788839Search in Google Scholar

12. Delitala AP. Subclinical Hyperthyroidism and the Cardiovascular Disease. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 2017; 49: 723-731.10.1055/s-0043-11789328915531Search in Google Scholar

13. Canaris GJ, Manowitz NR, Mayor G& Ridgway EC. The Colorado thyroid disease prevalence study. Archives of internal medicine. 2000; 160: 526-534.10.1001/archinte.160.4.52610695693Search in Google Scholar

14. Duntas LH. Thyroid disease and lipids. Thyroid : Official Journal of the American Thyroid Association. 2002; 12: 287-293.10.1089/1050725025294940512034052Search in Google Scholar

15. Biondi B& Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocrine reviews. 2008; 29: 76-131.10.1210/er.2006-004317991805Search in Google Scholar

16. Delitala AP, Fanciulli G, Zoledziewska M, Pitzalis M, Pusceddu P, Frongia P, Puddu L, Errigo A, Maioli M, Delitala G& Pes GM. Allelic variant in CTLA4 is associated with thyroid failure and faster beta-cell exhaustion in latent autoimmune diabetes in adults. Journal of diabetes. 2015; 7: 68-73.10.1111/1753-0407.1213725695113Search in Google Scholar

17. Delitala AP, Steri M, Fiorillo E, Marongiu M, Lakatta EG, Schlessinger D& Cucca F. Adipocytokine correlations with thyroid function and autoimmunity in euthyroid sardinians. Cytokine. 2018; 111: 189-193.10.1016/j.cyto.2018.08.027638559830173124Search in Google Scholar

18. Medici M, Porcu E, Pistis G, Teumer A, Brown SJ, Jensen RA, Rawal R, Roef GL, Plantinga TS, Vermeulen SH, Lahti J, Simmonds MJ, Husemoen LL, Freathy RM, Shields BM, Pietzner D, Nagy R, Broer L, Chaker L, Korevaar TI, Plia MG, Sala C, Volker U, Richards JB, Sweep FC, Gieger C, Corre T, Kajantie E, Thuesen B, Taes YE, Visser WE, Hattersley AT, Kratzsch J, Hamilton A, Li W, Homuth G, Lobina M, Mariotti S, Soranzo N, Cocca M, Nauck M, Spielhagen C, Ross A, Arnold A, van de Bunt M, Liyanarachchi S, Heier M, Grabe HJ, Masciullo C, Galesloot TE, Lim EM, Reischl E, Leedman PJ, Lai S, Delitala A, Bremner AP, Philips DI, Beilby JP, Mulas A, Vocale M, Abecasis G, Forsen T, James A, Widen E, Hui J, Prokisch H, Rietzschel EE, Palotie A, Feddema P, Fletcher SJ, Schramm K, Rotter JI, Kluttig A, Radke D, Traglia M, Surdulescu GL, He H, Franklyn JA, Tiller D, Vaidya B, de Meyer T, Jorgensen T, Eriksson JG, O'Leary PC, Wichmann E, Hermus AR, Psaty BM, Ittermann T, Hofman A, Bosi E, Schlessinger D, Wallaschofski H, Pirastu N, Aulchenko YS, de la Chapelle A, Netea-Maier RT, Gough SC, Meyer Zu Schwabedissen H, Frayling TM, Kaufman JM, Linneberg A, Raikkonen K, Smit JW, Kiemeney LA, Rivadeneira F, Uitterlinden AG, Walsh JP, Meisinger C, den Heijer M, Visser TJ, Spector TD, Wilson SG, Volzke H, Cappola A, Toniolo D, Sanna S, Naitza S& Peeters RP. Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease. PLoS genetics. 2014; 10: e1004123.10.1371/journal.pgen.1004123393713424586183Search in Google Scholar

19. Kochummen E, Marwa A, Umpaichitra V, Perez-Colon S& Chin VL. Screening for autoimmune thyroiditis and celiac disease in minority children with type 1 diabetes. Journal of pediatric endocrinology & metabolism: JPEM. 2018; 31: 879-885.10.1515/jpem-2017-025429949512Search in Google Scholar

20. Delitala AP, Pes GM, Fanciulli G, Maioli M, Secchi G, Sanciu F, Delitala G& Manetti R. Organ-specific antibodies in LADA patients for the prediction of insulin dependence. Endocrine research. 2016; 41: 207-212.10.3109/07435800.2015.113693426865056Search in Google Scholar

21. Delitala AP, Pilia MG, Ferreli L, Loi F, Curreli N, Balaci L, Schlessinger D& Cucca F. Prevalence of unknown thyroid disorders in a Sardinian cohort. European Journal of Endocrinology. 2014; 171: 143-149.10.1530/EJE-14-0182452752724917664Search in Google Scholar

22. Vanderpump MP& Tunbridge WM. Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid: official journal of the American Thyroid Association. 2002; 12: 839-847.10.1089/10507250276101645812487765Search in Google Scholar

23. Lucas A, Julian MT, Canton A, Castell C, Casamitjana R, Martinez-Caceres EM& Granada ML. Undiagnosed thyroid dysfunction, thyroid antibodies, and iodine excretion in a Mediterranean population. Endocrine. 2010; 38: 391-396.10.1007/s12020-010-9397-220972723Search in Google Scholar

24. Volzke H, Ludemann J, Robinson DM, Spieker KW, Schwahn C, Kramer A, John U& Meng W. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid: Official Journal of the American Thyroid Association. 2003; 13: 803-810.10.1089/10507250376849968014558922Search in Google Scholar

25. Delitala AP, Fanciulli G, Pes GM, Maioli M& Delitala G. Thyroid Hormones, Metabolic Syndrome and Its Components. Endocrine, metabolic & immune disorders drug targets. 2017; 17: 56-62.10.2174/187153031766617032010522128322173Search in Google Scholar

26. Delitala AP, Fanciulli G, Maioli M& Delitala G. Subclinical hypothyroidism, lipid metabolism and cardiovascular disease. European journal of internal medicine. 2017; 38: 17-24.10.1016/j.ejim.2016.12.01528040402Search in Google Scholar

27. Pearce EN. Update in lipid alterations in subclinical hypothyroidism. The Journal of Clinical Endocrinology and Metabolism. 2012; 97: 326-333.10.1210/jc.2011-253222205712Search in Google Scholar

28. Pearce EN. Hypothyroidism and dyslipidemia: modern concepts and approaches. Current cardiology reports. 2004; 6: 451-456.10.1007/s11886-004-0054-315485607Search in Google Scholar

29. Asvold BO, Vatten LJ, Nilsen TI& Bjoro T. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. European Journal of Endocrinology. 2007; 156: 181-186.Search in Google Scholar

30. Vierhapper H, Nardi A, Grosser P, Raber W& Gessl A. Low-density lipoprotein cholesterol in subclinical hypothyroidism. Thyroid: Official Journal of the American Thyroid Association. 2000; 10: 981-984.10.1089/thy.2000.10.98111128726Search in Google Scholar

31. Hueston WJ& Pearson WS. Subclinical Hypothyroidism and the risk of Hypercholesterolemia. Annals of family medicine. 2004; 2: 351-355.10.1370/afm.79146669415335135Search in Google Scholar

32. Tian L, Song Y, Xing M, Zhang W, Ning G, Li X, Yu C, Qin C, Liu J, Tian X, Sun X, Fu R, Zhang L, Zhang X, Lu Y, Zou J, Wang L, Guan Q, Gao L& Zhao J. A novel role for thyroid-stimulating hormone: up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase expression through the cyclic adenosine monophosphate/protein kinase A/cyclic adenosine monophosphate-responsive element binding protein pathway. Hepatology. 2010; 52: 1401-1409.10.1002/hep.2380020648556Search in Google Scholar

33. Adrees M, Gibney J, El-Saeity N& Boran G. Effects of 18 months of L-T4 replacement in women with subclinical hypothyroidism. Clinical Endocrinology. 2009; 71: 298-303.10.1111/j.1365-2265.2008.03509.x19094068Search in Google Scholar

34. Tzotzas T, Krassas GE, Konstantinidis T& Bougoulia M. Changes in lipoprotein (a) levels in overt and subclinical hypothyroidism before and during treatment. Thyroid: official journal of the American Thyroid Association. 2000; 10: 803-808.10.1089/thy.2000.10.80311041458Search in Google Scholar

35. Brenta G, Berg G, Arias P, Zago V, Schnitman M, Muzzio ML, Sinay I& Schreier L. Lipoprotein alterations, hepatic lipase activity, and insulin sensitivity in subclinical hypothyroidism: response to L-T (4) treatment. Thyroid: Official Journal of the American Thyroid Association. 2007; 17: 453-460.10.1089/thy.2006.030217542675Search in Google Scholar

36. Ito M, Takamatsu J, Sasaki I, Hiraiwa T, Fukao A, Murakami Y, Isotani H, Miyauchi A, Kuma K& Hanafusa T. Disturbed metabolism of remnant lipoproteins in patients with subclinical hypothyroidism. The American Journal of Medicine. 2004; 117: 696-699.10.1016/j.amjmed.2004.04.02715501208Search in Google Scholar

37. Kim CS, Kang JG, Lee SJ, Ihm SH, Yoo HJ, Nam JS, Ahn CW& Kim KR. Relationship of low-density lipoprotein (LDL) particle size to thyroid function status in Koreans. Clinical Endocrinology. 2009; 71: 130-136.10.1111/j.1365-2265.2008.03436.x19178521Search in Google Scholar

38. Santini F, Marzullo P, Rotondi M, Ceccarini G, Pagano L, Ippolito S, Chiovato L& Biondi B. Mechanisms in Endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease. European Journal of Endocrinology. 2014; 171: R137-152.10.1530/EJE-14-006725214234Search in Google Scholar

39. Delitala AP, Scuteri A, Fiorillo E, Lakatta EG, Schlessinger D& Cucca F. Role of Adipokines in the Association between Thyroid Hormone and Components of the Metabolic Syndrome. Journal of Clinical Medicine. 2019; 8.10.3390/jcm8060764661711531151171Search in Google Scholar

40. Meisinger C, Ittermann T, Tiller D, Agger C, Nauck M, Schipf S, Wallaschofski H, Jorgensen T, Linneberg A, Thiery J, Kluttig A, Greiser KH, Werdan K, Burkhardt K& Volzke H. Sex-specific associations between thyrotropin and serum lipid profiles. Thyroid: Official Journal of the American Thyroid Association. 2014; 24: 424-432.10.1089/thy.2013.025924102572Search in Google Scholar

41. Delitala AP, Steri M, Pilia MG, Dei M, Lai S, Delitala G, Schlessinger D& Cucca F. Menopause modulates the association between thyrotropin levels and lipid parameters: The SardiNIA study. Maturitas. 2016; 92: 30-34.10.1016/j.maturitas.2016.07.003550128427621235Search in Google Scholar

42. Delitala AP, Terracciano A, Fiorillo E, Orru V, Schlessinger D& Cucca F. Depressive symptoms, thyroid hormone and autoimmunity in a population-based cohort from Sardinia. Journal of affective disorders. 2016; 191: 82-87.10.1016/j.jad.2015.11.019471596126655116Search in Google Scholar

43. Obregon MJ. Adipose tissues and thyroid hormones. Frontiers in Physiology. 2014; 5: 479.10.3389/fphys.2014.00479Search in Google Scholar

44. Delitala AP, Manzocco M, Sinibaldi FG& Fanciulli G. Thyroid function in elderly people: The role of subclinical thyroid disorders in cognitive function and mood alterations. International Journal of Clinical Practice. 2018; 72: e13254.10.1111/ijcp.13254Search in Google Scholar

45. Klein I& Ojamaa K. Thyroid hormone and the cardiovascular system: from theory to practice. The Journal of Clinical Endocrinology and Metabolism. 1994; 78: 1026-1027.Search in Google Scholar

46. Klein I& Ojamaa K. Thyroid hormone and the heart. The American Journal of Medicine. 1996; 101: 459-460.10.1016/S0002-9343(96)00310-5Search in Google Scholar

47. Kahaly GJ. Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid: Official Journal of the American Thyroid Association. 2000; 10: 665-679.10.1089/1050725005013774311014311Search in Google Scholar

48. Ladenson PW, Sherman SI, Baughman KL, Ray PE& Feldman AM. Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. Proceedings of the National Academy of Sciences of the United States of America. 1992; 89: 5251-5255.10.1073/pnas.89.12.5251492691376915Search in Google Scholar

49. Kahaly GJ, Nieswandt J& Mohr-Kahaly S. Cardiac risks of hyperthyroidism in the elderly. Thyroid: official journal of the American Thyroid Association. 1998; 8: 1165-1169.10.1089/thy.1998.8.11659920373Search in Google Scholar

50. Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J& Rodondi N. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Annals of Internal Medicine. 2008; 148: 832-845.10.7326/0003-4819-148-11-200806030-0022518490668Search in Google Scholar

51. Kvetny J, Heldgaard PE, Bladbjerg EM& Gram J. Subclinical Hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clinical endocrinology. 2004; 61: 232-238.10.1111/j.1365-2265.2004.02088.x15272919Search in Google Scholar

52. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P& Michelangeli V. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Archives of internal medicine. 2005; 165: 2467-2472.10.1001/archinte.165.21.246716314542Search in Google Scholar

53. Razvi S, Shakoor A, Vanderpump M, Weaver JU& Pearce SH. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. The Journal of Clinical Endocrinology and Metabolism. 2008; 93: 2998-3007.10.1210/jc.2008-016718505765Search in Google Scholar

54. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT, Vanderpump MP, Newman AB, Cornuz J, Franklyn JA, Westendorp RG, Vittinghoff E, Gussekloo J& Thyroid Studies C. Subclinical Hypothyroidism and the risk of coronary heart disease and mortality. Jama. 2010; 304: 1365-1374.10.1001/jama.2010.1361Search in Google Scholar

55. Zhao M, Yang T, Chen L, Tang X, Guan Q, Zhang B, Zhang X, Zhang H, Wang C, Xu J, Hou X, Li Q, Yu C, Zhao Y, Fang L, Yuan Z, Xue F, Ning G, Gao L, Xu C& Zhao J. Subclinical Hypothyroidism might worsen the effects of aging on serum lipid profiles: a population-based case-control study. Thyroid: official journal of the American Thyroid Association. 2015; 25: 485-493.10.1089/thy.2014.0219Search in Google Scholar

56. Razvi S, Ingoe L, Keeka G, Oates C, McMillan C& Weaver JU. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. The Journal of Clinical Endocrinology and Metabolism. 2007; 92: 1715-1723.10.1210/jc.2006-1869Search in Google Scholar

57. Caraccio N, Ferrannini E& Monzani F. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab. 2002; 87: 1533-1538.10.1210/jcem.87.4.8378Search in Google Scholar

58. Kong WM, Sheikh MH, Lumb PJ, Naoumova RP, Freedman DB, Crook M, Dore CJ& Finer N. A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism. The American Journal of Medicine. 2002; 112: 348-354.10.1016/S0002-9343(02)01022-7Search in Google Scholar

59. Villar HC, Saconato H, Valente O& Atallah AN. Thyroid hormone replacement for subclinical hypothyroidism. The Cochrane database of systematic reviews. 2007; CD003419.10.1002/14651858.CD003419.pub2661097417636722Search in Google Scholar

60. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL& Wolfson SK, Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. The New England Journal of Medicine. 1999; 340: 14-22.10.1056/NEJM1999010734001039878640Search in Google Scholar

61. Peixoto de Miranda EJ, Bittencourt MS, Pereira AC, Goulart AC, Santos IS, Lotufo PA& Bensenor IM. Subclinical hypothyroidism is associated with higher carotid intima-media thickness in cross-sectional analysis of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Nutrition, metabolism, and cardiovascular diseases: NMCD. 2016; 26: 915-921.10.1016/j.numecd.2016.06.00527389191Search in Google Scholar

62. Monzani F, Caraccio N, Kozakowa M, Dardano A, Vittone F, Virdis A, Taddei S, Palombo C& Ferrannini E. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. The Journal of Clinical Endocrinology and Metabolism. 2004; 89: 2099-2106.10.1210/jc.2003-03166915126526Search in Google Scholar

63. Kim SK, Kim SH, Park KS, Park SW& Cho YW. Regression of the increased common carotid artery-intima media thickness in subclinical hypothyroidism after thyroid hormone replacement. Endocrine Journal. 2009; 56: 753-758.10.1507/endocrj.K09E-049Search in Google Scholar

64. Gungor O, Celik A, Kebapcilar L, Karaoglu O, Ersan S, Atilla K, Canda T, Bayraktar F& Yesil S. Incidence of thyroid dysfunction and thyroid cancer in renal transplant recipients: a single center experience. Renal failure. 2010; 32: 167-171.10.3109/0886022090354111920199177Search in Google Scholar

65. Hosseini SM, Bakhtyari EK, Heshmat-Ghahdarijani K& Khalili N. Evaluation of endothelial function in exogenous subclinical hyperthyroidism and the effect of treatment. Advanced Biomedical research. 2016; 5: 173.10.4103/2277-9175.194800515700428028513Search in Google Scholar

66. Lioudaki E, Mavroeidi NG, Mikhailidis DP& Ganotakis ES. Subclinical Hypothyroidism and vascular risk: an update. Hormones. 2013; 12: 495-506.10.14310/horm.2002.143724457397Search in Google Scholar

67. Cabral MD, Teixeira P, Soares D, Leite S, Salles E& Waisman M. Effects of thyroxine replacement on endothelial function and carotid artery intima-media thickness in female patients with mild subclinical hypothyroidism. Clinics. 2011; 66: 1321-1328.Search in Google Scholar

68. Delitala AP, Filigheddu F, Orru M, AlGhatrif M, Steri M, Pilia MG, Scuteri A, Lobina M, Piras MG, Delitala G, Lakatta EG, Schlessinger D& Cucca F. No evidence of association between subclinical thyroid disorders and common carotid intima medial thickness or atherosclerotic plaque. Nutrition, metabolism, and cardiovascular diseases: NMCD. 2015; 25: 1104-1110.10.1016/j.numecd.2015.09.001468442426615224Search in Google Scholar

69. Zhao T, Chen B, Zhou Y, Wang X, Zhang Y, Wang H& Shan Z. Effect of levothyroxine on the progression of carotid intima-media thickness in subclinical hypothyroidism patients: a meta-analysis. BMJ open. 2017; 7: e016053.10.1136/bmjopen-2017-016053566533029061604Search in Google Scholar

70. Masaki M, Komamura K, Goda A, Hirotani S, Otsuka M, Nakabo A, Fukui M, Fujiwara S, Sugahara M, Lee-Kawabata M, Tsujino T, Koshiba M& Masuyama T. Elevated arterial stiffness and diastolic dysfunction in subclinical hypothyroidism. Circulation Journal: Official Journal of the Japanese Circulation Society. 2014: 78: 1494-1500.10.1253/circj.CJ-13-1556Search in Google Scholar

71. Wang J, Zheng X, Sun M, Wang Z, Fu Q, Shi Y, Cao M, Zhu Z, Meng C, Mao J, Yang F, Huang X, Xu J, Zhou H, Duan Y, He W, Zhang M, Yang T& Group RS. Low serum free thyroxine concentrations associate with increased arterial stiffness in euthyroid subjects: a population-based cross-sectional study. Endocrine. 2015; 50: 465-473.10.1007/s12020-015-0602-125987347Search in Google Scholar

72. Kwon BJ, Roh JW, Lee SH, Lim SM, Park CS, Kim DB, Jang SW, Chang K, Kim HY& Ihm SH. A high normal thyroid-stimulating hormone is associated with arterial stiffness, central systolic blood pressure, and 24-hour systolic blood pressure in males with treatment-naive hypertension and euthyroid. International Journal of Cardiology. 2014; 177: 949-956.10.1016/j.ijcard.2014.09.20025449506Search in Google Scholar

73. Delitala AP, Orru M, Filigheddu F, Pilia MG, Delitala G, Ganau A, Saba PS, Decandia F, Scuteri A, Marongiu M, Lakatta EG, Strait J& Cucca F. Serum free thyroxine levels are positively associated with arterial stiffness in the SardiNIA study. Clinical Endocrinology. 2015; 82: 592-597.10.1111/cen.12532427540824954304Search in Google Scholar

74. Peleg RK, Efrati S, Benbassat C, Fygenzo M& Golik A. The effect of levothyroxine on arterial stiffness and lipid profile in patients with subclinical hypothyroidism. Thyroid: Official Journal of the American Thyroid Association. 2008; 18: 825-830.10.1089/thy.2007.035918651824Search in Google Scholar

75. Laugesen E, Moser E, Sikjaer T, Poulsen PL& Rejnmark L. Arterial Stiffness and Central Hemodynamics in Thyroidectomized Patients on Long-Term Substitution Therapy with Levothyroxine. Thyroid: official journal of the American Thyroid Association. 2016; 26: 779-784.10.1089/thy.2015.060027029953Search in Google Scholar

76. Delitala AP, Delitala G, Sioni P& Fanciulli G. Thyroid hormone analogs for the treatment of dyslipidemia: past, present, and future. Current medical research and opinion 2017; 33: 1985-1993.10.1080/03007995.2017.133025928498022Search in Google Scholar

77. Zhao M, Liu L, Wang F, Yuan Z, Zhang X, Xu C, Song Y, Guan Q, Gao L, Shan Z, Zhang H& Zhao J. A Worthy Finding: Decrease in Total Cholesterol and Low-Density Lipoprotein Cholesterol in Treated Mild Subclinical Hypothyroidism. Thyroid: Official Journal of the American Thyroid Association. 2016; 26: 1019-1029.10.1089/thy.2016.001027270263Search in Google Scholar

78. Anagnostis P, Efstathiadou ZA, Slavakis A, Selalmatzidou D, Poulasouchidou M, Katergari S, Karathanasi E, Dogramatzi F& Kita M. The effect of L-thyroxine substitution on lipid profile, glucose homeostasis, inflammation and coagulation in patients with subclinical hypothyroidism. International Journal of Clinical Practice. 2014; 68: 857-863.10.1111/ijcp.1239424548294Search in Google Scholar

79. Kowalska I, Borawski J, Nikolajuk A, Budlewski T, Otziomek E, Gorska M& Straczkowski M. Insulin sensitivity, plasma adiponectin and sICAM-1 concentrations in patients with subclinical hypothyroidism: response to levothyroxine therapy. Endocrine. 2011; 40: 95-101.10.1007/s12020-011-9446-521424182Search in Google Scholar

80. Sigal GA, Medeiros-Neto G, Vinagre JC, Diament J& Maranhao RC. Lipid metabolism in subclinical hypothyroidism: plasma kinetics of triglyceride-rich lipoproteins and lipid transfers to high-density lipoprotein before and after levothyroxine treatment. Thyroid: Official Journal of the American Thyroid Association. 2011; 21: 347-353.10.1089/thy.2010.031321385074Search in Google Scholar

81. Efstathiadou Z, Bitsis S, Milionis HJ, Kukuvitis A, Bairaktari ET, Elisaf MS& Tsatsoulis A. Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? European Journal of Endocrinology. 2001; 145: 705-710.Search in Google Scholar

82. Iqbal A, Jorde R& Figenschau Y. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromso Study. Journal of Internal Medicine. 2006; 260: 53-61.10.1111/j.1365-2796.2006.01652.x16789979Search in Google Scholar

83. Fadeyev VV, Sytch J, Kalashnikov V, Rojtman A, Syrkin A& Melnichenko G. Levothyroxine replacement therapy in patients with subclinical hypothyroidism and coronary artery disease. Endocrine practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2006; 12: 5-17.10.4158/EP.12.1.516524858Search in Google Scholar

84. Gullu S, Sav H& Kamel N. Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. European Journal of Endocrinology. 2005; 152: 355-361.10.1530/eje.1.0185715757851Search in Google Scholar

85. Meier C, Staub JJ, Roth CB, Guglielmetti M, Kunz M, Miserez AR, Drewe J, Huber P, Herzog R& Muller B. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). The Journal of Clinical Endocrinology and Metabolism. 2001; 86: 4860-4866.10.1210/jcem.86.10.797311600554Search in Google Scholar

86. Paoli M, Bellabarba G, Velazquez E, Mendoza S, Molina C, Wang P& Glueck CJ. Sex steroids, lipids, and lipoprotein cholesterols in women with subclinical and overt hypothyroidism before and after L-thyroxine therapy. Clinica chimica acta; InternationalJjournal of Clinical Chemistry. 1998; 275: 81-91.10.1016/S0009-8981(98)00074-6Search in Google Scholar

87. Romaldini JH, Biancalana MM, Figueiredo DI, Farah CS& Mathias PC. Effect of L-thyroxine administration on antithyroid antibody levels, lipid profile, and thyroid volume in patients with Hashimoto's thyroiditis. Thyroid: Official Journal of the American Thyroid Association. 1996; 6: 183-188.Search in Google Scholar

88. Jaeschke R, Guyatt G, Gerstein H, Patterson C, Molloy W, Cook D, Harper S, Griffith L& Carbotte R. Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? Journal of General Internal Medicine. 1996; 11: 744-749.Search in Google Scholar

89. Ito M, Kitanaka A, Arishima T, Kudo T, Nishihara E, Kubota S, Amino N, Hiraiwa T, Hanafusa T& Miyauchi A. Effect of L-thyroxine replacement on apolipoprotein B-48 in overt and subclinical hypothyroid patients. Endocrine Journal 2013 60 65-71.10.1507/endocrj.EJ12-0226Search in Google Scholar

90. Ito M, Arishima T, Kudo T, Nishihara E, Ohye H, Kubota S, Fukata S, Amino N, Kuma K, Sasaki I, Hiraiwa T, Hanafusa T, Takamatsu J& Miyauchi A. Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients. The Journal of Clinical Endocrinology and Metabolism. 2007; 92: 608-611.10.1210/jc.2006-1605Search in Google Scholar

91. Arem R, Escalante DA, Arem N, Morrisett JD& Patsch W. Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a). Metabolism: clinical and experimental. 1995; 44: 1559-1563.10.1016/0026-0495(95)90075-6Search in Google Scholar

92. Bilic-Komarica E, Beciragic A& Junuzovic D. Effects of treatment with L-thyroxin on glucose regulation in patients with subclinical hypothyroidism. Medical archives. 2012; 66: 364-368.10.5455/medarh.2012.66.364-36823409511Search in Google Scholar

93. Tagami T, Tamanaha T, Shimazu S, Honda K, Nanba K, Nomura H, Yoriko SU, Usui T, Shimatsu A& Naruse M. Lipid profiles in the untreated patients with Hashimoto thyroiditis and the effects of thyroxine treatment on subclinical hypothyroidism with Hashimoto thyroiditis. Endocrine Journal. 2010; 57: 253-258.10.1507/endocrj.K09E-315Search in Google Scholar

94. Mikhail GS, Alshammari SM, Alenezi MY, Mansour M& Khalil NA. Increased atherogenic low-density lipoprotein cholesterol in untreated subclinical hypothyroidism. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2008; 14: 570-575.10.4158/EP.14.5.57018753099Search in Google Scholar

95. Serter R, Demirbas B, Korukluoglu B, Culha C, Cakal E& Aral Y. The effect of L-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism. Journal of Endocrinological investigation. 2004; 27: 897-903.10.1007/BF0334753015762035Search in Google Scholar

96. Perez A, Cubero JM, Sucunza N, Ortega E, Arcelus R, Rodriguez-Espinosa J, Ordonez-Llanos J& Blanco-Vaca F. Emerging cardiovascular risk factors in subclinical hypothyroidism: lack of change after restoration of euthyroidism. Metabolism: clinical and experimental. 2004; 53: 1512-1515.10.1016/j.metabol.2004.05.01615536611Search in Google Scholar

97. Ganotakis ES, Mandalaki K, Tampakaki M, Malliaraki N, Mandalakis E, Vrentzos G, Melissas J& Castanas E. Subclinical hypothyroidism and lipid abnormalities in older women attending a vascular disease prevention clinic: effect of thyroid replacement therapy. Angiology. 2003; 54: 569-576.10.1177/00033197030540050614565632Search in Google Scholar

98. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, Salvetti A, Ferrannini E& Monzani F. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. The Journal of Clinical Endocrinology and Metabolism. 2003; 88: 3731-3737.10.1210/jc.2003-03003912915662Search in Google Scholar

99. Milionis HJ, Efstathiadou Z, Tselepis AD, Bairaktari ET, Tsironis LD, Tsatsoulis A& Elisaf MS. Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine. Thyroid: Official Journal of the American Thyroid Association. 2003; 13: 365-369.10.1089/10507250332166985712804105Search in Google Scholar

100. Yildirimkaya M, Ozata M, Yilmaz K, Kilinc C, Gundogan MA& Kutluay T. Lipoprotein(a) concentration in subclinical hypothyroidism before and after levo-thyroxine therapy. Endocrine Journal. 1996; 43: 731-736.10.1507/endocrj.43.7319075615Search in Google Scholar

101. Bogner U, Arntz HR, Peters H& Schleusener H. Subclinical hypothyroidism and hyperlipoproteinaemia: indiscriminate L-thyroxine treatment not justified. Acta endocrinologica. 1993; 128: 202-206.10.1530/acta.0.12802028480467Search in Google Scholar

102. Arem R& Patsch W. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy. Archives of internal medicine. 1990; 150: 2097-2100.10.1001/archinte.1990.00390210077017Search in Google Scholar

103. Adamarczuk-Janczyszyn M, Zdrojowy-Welna A, Rogala N, Zatonska K& Bednarek-Tupikowska G. Evaluation of Selected Atherosclerosis Risk Factors in Women with Subclinical Hypothyroidism Treated with L-Thyroxine. Advances in clinical and experimental medicine: Official organ Wroclaw Medical University. 2016; 25: 457-463.10.17219/acem/3855527629733Search in Google Scholar

104. Miura S, Iitaka M, Yoshimura H, Kitahama S, Fukasawa N, Kawakami Y, Sakurai S, Urabe M, Sakatsume Y, Ito K& et al. Disturbed lipid metabolism in patients with Subclinical Hypothyroidism: effect of L-thyroxine therapy. Internal Medicine. 1994; 33: 413-417.10.2169/internalmedicine.33.4137949641Search in Google Scholar